Photo from Tom Powles/Twitter
Feb 5, 2024, 15:59
Tom Powles: Summary of clinical trials in advanced non-clear cell RCC GU24
Tom Powles, Director of Barts Cancer Centre, shared a post on X/Twitter:
“Summary of clinical trials in advanced non-clear cell RCC GU24. The studies are small and pathology mixed ‘the moons of Jupiter’. The focus on PD1 and VEGF was not driven by the biology. Large randomised trials such as SAMETA exploring MET in selected papillary seems like progress.”
Source: Tom Powles/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 06:49
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12